Myofunctional therapy app for severe apnea-hypopnea sleep obstructive syndrome: Pilot randomized controlled trial

Background: Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea–hypopnea syndrome (OSAHS) to perform oropharyngeal exerci...

ver descrição completa

Detalhes bibliográficos
Autores: O’Connor-Reina, C. (Carlos)|||/items/5f02abf5-9355-4cf9-868a-f6eb1df7b4d7, Garcia, J.M.I. (José Maria Ignacio)|||/items/0e7c19a9-d9b7-4824-a139-e04237c4bf72, Rodriguez-Ruiz, E. (Elisa)|||/items/363c6828-398d-42a2-a567-3a09ab9574c0, Morillo-Dominguez, M.C. (Maria-Del-Carmen)|||/items/f16cc3dc-1038-468a-888f-26b09f8b332a, Barrios, V.I. (Victoria Ignacio)|||/items/5c899e56-66bf-424a-8574-cdaeb7c86a90, Baptista-Jardin, P.M. (Peter Michael)|||/items/66ecbc41-d708-4b43-a527-b733813d5195, Casado-Morente, J.C. (Juan Carlos)|||/items/010c1389-3d47-424f-acaf-33ed59837224, Garcia-Iriarte, M.T. (Maria Teresa)|||/items/897c4487-cc22-45db-9334-9e92d937055f, Plaza, G. (Guillermo)|||/items/769de495-2430-40c5-b0c0-9739120b7868
Tipo de documento: artigo
Data de publicação:2020
País:España
Recursos:Universidad de Navarra
Repositório:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglês
OAI Identifier:oai:dadun.unav.edu:10171/67166
Acesso em linha:https://hdl.handle.net/10171/67166
Access Level:Acceso aberto
Palavra-chave:Myofunctional therapy
Oropharyngeal exercises
mHealth
Sleep apnea
Smartphone app
App
Sleep
Therapy
Apnea
Randomized trial
Efficacy
Descrição
Resumo:Background: Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea–hypopnea syndrome (OSAHS) to perform oropharyngeal exercises. Objective: We conducted a pilot randomized trial to evaluate the effects of the app in patients with severe OSAHS. Methods: Forty patients with severe OSAHS (apnea–hypoxia index [AHI]>30) were enrolled prospectively and randomized into an intervention group that used the app for 90 sessions or a control group. Anthropometric measures, Epworth Sleepiness Scale (0-24), Pittsburgh Sleep Quality Index (0-21), Iowa Oral Performance Instrument (IOPI) scores, and oxygen desaturation index were measured before and after the intervention. Results: After the intervention, 28 patients remained. No significant changes were observed in the control group; however, the intervention group showed significant improvements in most metrics. AHI decreased by 53.4% from 44.7 (range 33.8-55.6) to 20.88 (14.02-27.7) events/hour (P<.001). The oxygen desaturation index decreased by 46.5% from 36.31 (27.19-43.43) to 19.4 (12.9-25.98) events/hour (P=.003). The IOPI maximum tongue score increased from 39.83 (35.32-45.2) to 59.06 (54.74-64.00) kPa (P<.001), and the IOPI maximum lip score increased from 27.89 (24.16-32.47) to 44.11 (39.5-48.8) kPa (P<.001). The AHI correlated significantly with IOPI tongue and lip improvements (Pearson correlation coefficient −0.56 and −0.46, respectively; both P<.001). The Epworth Sleepiness Scale score decreased from 10.33 (8.71-12.24) to 5.37 (3.45-7.28) in the app group (P<.001), but the Pittsburgh Sleep Quality Index did not change significantly. Conclusions: Orofacial exercises performed using an mHealth app reduced OSAHS severity and symptoms, and represent a promising treatment for OSAHS. Trial Registration: Spanish Registry of Clinical Studies AWGAPN-2019-01, ClinicalTrials.gov NCT04438785; https://clinicaltrials.gov/ct2/show/NCT04438785